The influence of folate pathway polymorphisms on high-dose methotrexaterelated toxicity and survival in children with non-Hodgkin malignant lymphoma

Online veröffentlicht: 10. Juli 2014

Seitenbereich: 289 - 292

Eingereicht: 01. Sept. 2013

Akzeptiert: 16. Sept. 2013

DOI: https://doi.org/10.2478/raon-2013-0076

Schlüsselwörter

childhood, non-Hodgkin lymphoma, folate pathway, polymorphism, high-dose methotrexate, toxicity

© by Vita Dolzan

This article is distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.